CompletedPhase 2NCT00660699

A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers

Studying Carcinoma of the ampulla of Vater

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
Benjamin Tan, M.D.
Washington University School of Medicine
Intervention
Gemcitabine(drug)
Enrollment
50 enrolled
Eligibility
18 years · All sexes
Timeline
20022012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00660699 on ClinicalTrials.gov

Other trials for Carcinoma of the ampulla of Vater

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the ampulla of Vater

← Back to all trials